Adrian Kinkaid, CEO Fusion Antibodies
Zak Mir talks to Adrian Kinkaid, CEO Fusion Antibodies, as the specialist in pre-clinical antibody discovery announces an update on its AI/ML-AbTM service offering.
Disclaimer & Declaration of Interest:
The information, investment views, and recommendations in this Zaks Traders Cafe interview are provided for general information purposes only. Nothing in this interview should be construed as a promotion or solicitation to buy or sell any financial product relating to any companies under discussion or referred to or to engage in or refrain from doing so or engage in any other transaction. Any opinions or comments are made to the best of the knowledge and belief of the commentator but no responsibility is accepted for actions based on such opinions or comments. The commentators may or may not hold investments in the companies under discussion.